With the right policies, advanced science, and strong leadership in government agencies, Donald Trump has the power to save ...
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
The recall is classified as the second-highest risk level to consumers — meaning use of or exposure to products with the potential contamination poses a remote threat of serious adverse health ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...
The Food and Drug Administration on Friday said the shortage ... In a statement, the FDA said it confirmed Novo Nordisk's "stated product availability and manufacturing capacity" of these ...
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...